Dow Up0.64% Nasdaq Up0.68%

Emergent BioSolutions, Inc. (EBS)

-NYQ
22.20 0.03(0.14%) Sep 18, 4:02PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Net Income 5,029   (20,236) 15,222   13,491  
Operating Activities, Cash Flows Provided By or Used In
Depreciation8,459  6,835  5,411  5,175  
Adjustments To Net Income6,873  (7,276)12,449  7,690  
Changes In Accounts Receivables(15,316)17,590  (30,494)24,276  
Changes In Liabilities1,659  (22,708)7,070  9,034  
Changes In Inventories5,238  (4,006)1,682  2,257  
Changes In Other Operating Activities(1,123)556  (2,694)(1,798)
Total Cash Flow From Operating Activities 10,819   (29,245) 8,641   60,125  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(4,810)(4,590)(7,601)(20,297)
Investments -   -   -   -  
Other Cash flows from Investing Activities -  (178,167)(1,753)(24,120)
Total Cash Flows From Investing Activities (4,810) (182,757) (9,354) (44,417)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock1,832  8,137  4,130  1,572  
Net Borrowings -  180,654  2,578  (1,117)
Other Cash Flows from Financing Activities(532)(487)(348) -  
Total Cash Flows From Financing Activities 1,909   192,874   7,510   647  
Effect Of Exchange Rate Changes(3)5  (20)(37)
Change In Cash and Cash Equivalents 7,915   (19,123) 6,777   16,318  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.